Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
---|
07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
07/13/2011 | EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
07/13/2011 | CN102123987A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
07/12/2011 | US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
07/12/2011 | US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
07/12/2011 | CA2577879C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon. |
07/07/2011 | WO2011081205A1 1,3,4-oxadiazole-2-carboxamide compound |
07/07/2011 | WO2011080444A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
07/07/2011 | US20110166164 THIAZOLO[5,4-d] PYRIMIDINES AND THEIR USE AS AGROCHEMICALS |
07/07/2011 | US20110165183 Piperidine derivatives as jak3 inhibitors |
07/07/2011 | CA2785679A1 1,3,4-oxadiazole-2-carboxamide compound |
07/07/2011 | CA2784152A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
07/06/2011 | CN101648962B C3/C3 fluoroquinolone dipolymer derivative taking s-triazolo-[3,4-b][1,3,4] thiadiazole as connecting chain and preparation method and application thereof |
07/05/2011 | US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
06/30/2011 | WO2011076687A1 Pyridinone derivatives and pharmaceutical compositions thereof |
06/30/2011 | WO2010132999A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics |
06/30/2011 | US20110160208 Diaryl-substituted five-membered heterocycle derivative |
06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
06/30/2011 | US20110159563 Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
06/29/2011 | EP2114937B1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals |
06/29/2011 | EP1730142B1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
06/29/2011 | CN102112473A Pyrrolidinyl-alkyl-amide derivatives, their preparation and their therapeutic application as ccr3 receptor ligands |
06/29/2011 | CN101565428B Preparation method of prulifloxacin |
06/28/2011 | US7968567 Compounds for the modulation of PPARγ activity |
06/28/2011 | US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis |
06/28/2011 | CA2602248C Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
06/28/2011 | CA2427206C Sulfamides as gamma-secretase inhibitors |
06/23/2011 | WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
06/23/2011 | WO2011075607A1 Novel inhibitors of hepatitis c virus replication |
06/23/2011 | WO2011075525A1 Process for preparing cannabinoid receptor ligands |
06/23/2011 | WO2011075522A1 Prodrug compounds useful as cannabinoid ligands |
06/23/2011 | WO2011074560A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
06/23/2011 | WO2011073347A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
06/23/2011 | WO2011073339A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
06/23/2011 | WO2011073316A1 4-aryl-butane-1,3-diamides |
06/23/2011 | WO2011073173A1 Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof |
06/23/2011 | WO2011072779A1 Thiazole derivatives for treating diseases such as cancer |
06/23/2011 | US20110152253 Spiroaminodihydrothiazine derivatives |
06/23/2011 | US20110152251 Compounds for modulating tlr2 |
06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
06/23/2011 | US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
06/23/2011 | CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
06/23/2011 | CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
06/23/2011 | CA2784067A1 Thiazole derivatives for the treatment of diseases such as cancer |
06/23/2011 | CA2783938A1 Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof |
06/23/2011 | CA2782950A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
06/23/2011 | CA2782947A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
06/22/2011 | EP2336136A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
06/22/2011 | EP2203448B1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
06/22/2011 | EP2054420B1 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof |
06/22/2011 | CN102105475A Spiroaminodihydrothiazine derivatives |
06/22/2011 | CN102105451A Glucokinase activators |
06/22/2011 | CN102101867A Thiazinogeldanamycin and preparation method and use thereof |
06/21/2011 | US7964722 Light-driven rotary molecular motors |
06/21/2011 | US7964623 Tricyclic benzopyrane compound |
06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
06/21/2011 | US7964361 Rigidized trimethine cyanine dyes |
06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
06/16/2011 | WO2011071109A1 Fused heterocyclic compound having amino group |
06/16/2011 | WO2011070781A1 Substituted aminothiazine derivative |
06/16/2011 | WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
06/16/2011 | US20110144343 Process for preparing cannabinoid receptor ligands |
06/16/2011 | US20110144104 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as ccr3 receptor ligands |
06/16/2011 | US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors |
06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
06/16/2011 | US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products |
06/16/2011 | US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors |
06/16/2011 | DE102009058280A1 Thiazolderivate Thiazole derivatives |
06/16/2011 | CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
06/15/2011 | EP2332943A1 Novel fused aminodihydrothiazine derivative |
06/15/2011 | EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain |
06/15/2011 | EP2331553A1 Hepatitis c virus inhibitors |
06/15/2011 | CN1926129B Double amide insecticides |
06/15/2011 | CN102093394A Lornoxicam tromethamine eutectic crystal |
06/15/2011 | CN102093393A Method for preparing prulifloxacin and intermediate product thereof |
06/15/2011 | CN101137661B Imidazothiazole derivative and method for producing same |
06/15/2011 | CN101137660B Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
06/14/2011 | US7960568 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
06/09/2011 | WO2010147969A3 Gamma secretase modulators |
06/09/2011 | US20110136782 Nitrogen-containing heterocyclic derivative and fungicide for agricultural and horticultural use |
06/09/2011 | US20110135603 Inhibitors of phosphatidylinositol 3-kinase |
06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
06/09/2011 | CA2781891A1 Novel tricyclic compounds |
06/09/2011 | CA2781010A1 Novel tricyclic compounds |
06/08/2011 | EP2328903A1 Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use |
06/08/2011 | EP2328890A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
06/08/2011 | EP2328871A2 Hedgehog pathway modulators |
06/08/2011 | EP1945648B1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof |
06/08/2011 | EP1757610B1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
06/08/2011 | CN102089314A Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
06/08/2011 | CN102089291A Cyclopentylacrylic acid amide derivative |
06/08/2011 | CN102089278A Compounds and compositions useful for the treatment of malaria |
06/08/2011 | CN101619070B Preparation method of tenoxicam |
06/08/2011 | CN101253181B Pyrido-thiazinium dyes |
06/07/2011 | US7956193 Intramolecular C-H amination with sulfonyl azides |